Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SIDI Program Will Standardize Ingredient Protocol – Supplement Trade Groups

This article was originally published in The Tan Sheet

Executive Summary

A voluntary protocol could prompt "a major paradigm shift for many in the [dietary supplement] industry by moving away from unique individualized questionnaires towards standardized documentation and information exchange," trade groups say
Advertisement

Related Content

PCA Indictments Send Warnings On Vendor Qualification, Responsibility
PCA Indictments Send Warnings On Vendor Qualification, Responsibility
SIDI Group Split Reflects Supplement Industry Disparate Interests
Fight Adulteration With Supplier Qualification Guide, Supplement Industry Says
Supplements Shielded From Spread Of Peanut Butter-Like Problems – Trades
SIDI could be useful for NDIs
SIDI update
Intellectual Property Concerns Spur New Supplement Initiatives For 2007
FDA Guidance Clarifies Labeling For Supplements Containing Food Allergens
FDA Guidance Clarifies Labeling For Supplements Containing Food Allergens

Topics

Advertisement
UsernamePublicRestriction

Register

PS099881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel